BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2020 3:43:52 AM | Browse: 682 | Download: 1551
 |
Received |
|
2020-02-14 16:07 |
|
Peer-Review Started |
|
2020-02-14 16:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-05-26 22:54 |
|
Revised |
|
2020-05-29 01:17 |
|
Second Decision |
|
2020-06-16 09:13 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-16 23:03 |
|
Articles in Press |
|
2020-06-16 23:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-07-03 07:18 |
|
Publish the Manuscript Online |
|
2020-07-07 03:43 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong-Beum Kim, Sang-Gon Park, Ran Hong, Seong-Ho Kang and Yong Sub Na |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning |
NRF-2015R1A5A2009070 |
|
| Corresponding Author |
Yong Sub Na, MD, Assistant Professor, Department of Pulmonology and Critical Care Medicine, Chosun University Hospital, 365 Pilmun-daero, Dong-gu, Gwangju 61453, South Korea. ebusters@chosun.ac.kr |
| Key Words |
Acute myeloid leukemia; Immunotherapy; Non-small cell lung cancer; Adverse events; Case report; |
| Core Tip |
In the treatment of non-small cell lung cancer (NSCLC), pembrolizumab has demonstrated significant efficacy, significant survival outcomes, long-lasting responses, and good safety profile. To the best of our knowledge, this is the first report of acute myelomonocytic leukemia during pembrolizumab in a patient with NSCLC. However, the precise underlying mechanism remains unknown. |
| Publish Date |
2020-07-07 03:43 |
| Citation |
Kim HB, Park SG, Hong R, Kang SH, Na YS. Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report. World J Clin Cases 2020; 8(13): 2833-2840 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i13/2833.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i13.2833 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
